Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yardena Samuels

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Scientific Reports|November 29, 2017
Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cellsRand Arafeh, Karen Flores, Alona Keren-Paz, et al.
Pigment Cell & Melanoma Research|April 18, 2018
Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanomaMichal Alon, Rafi Emmanuel, Nouar Qutob, et al.
Oncotarget|March 14, 2019
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.
Oncotarget|August 23, 2018
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.
Cancer Biology & Therapy|May 25, 2006
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasmsKentaro Nakayama, Naomi Nakayama, Robert J Kurman, et al.
Biochemical and Biophysical Research Communications|July 7, 2010
IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brainGiselle Y Lopez, Zachary J Reitman, David Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulationKajsa Ericson, Christine Gan, Ian Cheong, et al.
Science (New York, N.Y.)|December 15, 2007
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutationsChuan-Hsiang Huang, Diana Mandelker, Oleg Schmidt-Kittler, et al.
BMC Genomics|September 26, 2012
Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanomaJared J Gartner, Sean Davis, Xiaomu Wei, et al.
Human Mutation|May 28, 2011
Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanomaXiaomu Wei, Angela Moncada-Pazos, Santiago Cal, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Scientific Reports|November 29, 2017
Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cellsRand Arafeh, Karen Flores, Alona Keren-Paz, et al.
Pigment Cell & Melanoma Research|April 18, 2018
Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanomaMichal Alon, Rafi Emmanuel, Nouar Qutob, et al.
Oncotarget|March 14, 2019
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.
Oncotarget|August 23, 2018
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.
Cancer Biology & Therapy|May 25, 2006
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasmsKentaro Nakayama, Naomi Nakayama, Robert J Kurman, et al.
Biochemical and Biophysical Research Communications|July 7, 2010
IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brainGiselle Y Lopez, Zachary J Reitman, David Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulationKajsa Ericson, Christine Gan, Ian Cheong, et al.
Science (New York, N.Y.)|December 15, 2007
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutationsChuan-Hsiang Huang, Diana Mandelker, Oleg Schmidt-Kittler, et al.
BMC Genomics|September 26, 2012
Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanomaJared J Gartner, Sean Davis, Xiaomu Wei, et al.
Human Mutation|May 28, 2011
Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanomaXiaomu Wei, Angela Moncada-Pazos, Santiago Cal, et al.
Pageof 11